Oncobiologics, Inc. 4
4 · Oncobiologics, Inc. · Filed Nov 14, 2016
Insider Transaction Report
Form 4
Gangloff Scott A.
SVP, Development & Mfrg
Transactions
- Conversion
Restricted Stock Units
2016-11-09−115,942→ 0 total - Exercise/Conversion
Common Stock
2016-11-09+115,942→ 115,942 total - Sale
Common Stock
2016-11-11$3.75/sh−37,369$140,134→ 78,573 total
Footnotes (4)
- [F1]Granted pursuant to the Issuer's 2015 Equity Incentive Plan.
- [F2]Each restricted stock unit ("RSU") represents the right to receive, at settlement, one (1) share of the Issuer's common stock.
- [F3]The RSUs vest upon the first to occur of (x) a change of control as defined in the award agreement and (y) the expiration of the 6 month lock-up period following the Issuer's initial public offering, in each case subject to continued service through such event.
- [F4]Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on November 9, 2016. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person.